To commercialise Cyclosporine Ophthalmic Nanoemulsion in MexicoLupin has signed a license and supply agreement with Huons Co Ltd for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion, 0.4mL Single-use Vial, in Mexico.Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion approved in South Korea, Peru and several countries in the Middle East for the treatment of dry eye syndrome and healing corneal ulcers. Thanks to its unique nanoparticle technology, it can relieve symptoms faster by increasing tear production in patients with suppressed tear formation due to keratoconjunctivitis sicca-related ocular inflammatory disease.“With this addition to our Ophthalmology portfolio, we continue to strengthen our commitment to provide better healthcare and Eyecare solutions to our patients, improving patient quality of life and vision,” said Dr Fabrice Egros, President – Corporate Development and Growth Markets, Lupin. Yohun Aum, Senior Director – Head of Global Business Division, Huons said, “Introducing our Cyclosporine Ophthalmic Nanoemulsion in Mexico is a significant milestone for Huons. We look forward to strengthening our partnership by supplying high-quality products for Mexico.”
